These targets were ... Repurposing Drug Shows Promise in Fighting Aggressive Brain Tumors Oct. 17, 2024 — Research provides evidence that a drug used to slow the progression of the disease ALS ...

Virtually every cell in the human body has an internal clock. These clocks take their cues from a central clock in the brain. In a normal, biological process called synchrony, the central clock ...

“In Canada, cancer immunotherapy for brain tumours is in early phases of development and requires proof-of-concept data. The support from Brain Cancer Canada fundraisers, donors, and philanthropists ...

Gliomas are the most common brain tumors, and many start off growing slowly as "low-grade" tumors before inevitably becoming aggressive, lethal, and "high grade." New research offers an ...

There is growing evidence that immune-positron emission tomography (immuno-PET) can provide a real-time quantitative readout ...

Glioblastoma, an aggressive brain cancer, syncs its internal clock to the host’s circadian rhythms, leveraging daily hormone cycles for growth. Blocking these signals slowed tumor progression in mice ...

Glioblastoma, an aggressive brain cancer, syncs its internal clock to the host’s circadian rhythms, leveraging daily hormone cycles for growth. Blocking these signals slowed tumor progression in mice ...

In a paper recently published in the journal Acta Neuropathologica Communications, DetermaCNI showed promise as a liquid biopsy method for diagnosing and profiling central nervous system tumors by ...

Jude Children’s Research Hospital, and they eventually transferred Gracelyn there. Imaging at St. Jude revealed that some of the tumor was still nestled in Gracelyn’s brain, and doctors wanted ...

Heart of the Brain – a brain cancer advocacy and fundraising organization – hosted the walk, raising $1.5 million this year for research and clinical trials, according to their website.